Galunisertib, TGFß receptor 1 inhibitor / Cancer immunotherapeutic, 25mg, CAS# 700874-72-2

Galunisertib, TGFß receptor 1 inhibitor / Cancer immunotherapeutic, 25mg, CAS# 700874-72-2

MGD·Na, Nitric oxide spin-trap reagent, 250mg, CAS# 91840-27-6

MGD·Na, Nitric oxide spin-trap reagent, 250mg, CAS# 91840-27-6

XL413·HCl, Cdc7 inhibitor/CRISPR enhancer, 5mg, CAS# 2062200-97-7

$60.00
8-Chloro-2-[(2S)-pyrrolidin-2-yl]-3H-[1]benzofuro[3,2-d]pyrimidin-4-one hydrochloride Purity: >98% by HPLC NMR (Conforms) Store -20°C Ship RT (1 per EA )

Manufacturer: Focus Biomolecules

SKU
10-4414-5mg-EA
XL413·HCl, Cdc7 inhibitor/CRISPR enhancer, 5mg, CAS# 2062200-97-7 is available to buy in increments of 1

Product Details

Download Details and Specifications

XL413 is a potent (IC50 = 4.8 nM) ATP-competitive inhibitor of the important DNA replication initiation kinase Cdc7 (DDK).1 It increases the efficiency of homology directed DNA repair in CRISPR-Cas9 gene editing.2 XL413 acted synergistically with other chemotherapy agents in various cancer models.3-5

CAS Number: 2062200-97-7

Manufacturer Part Number/SKU: 10-4414-5mg-EA

Tags: Focus Biomolecules